Introducing NaviDKD™
The first and only scientifically-proven predictive screening for diabetes-related kidney disease (DKD).
Know your risk. Change your life.™
The Problem
One in three adults with diabetes will develop kidney disease.
And, in 90% of cases, they won’t know they have it until it has advanced to the point where they need dialysis or a kidney transplant to survive, as it develops slowly and without symptoms.
We can identify high risk of kidney disease before symptoms arise.
Proactively assessing risk 10+ years in advance of clinical signs and symptoms, NaviDKD provides the opportunity to treat with therapeutics and technologies to change the outcome.
Who is NaviDKD for?
NaviDKD is validated for people 18 years of age or older, diagnosed with type 1, type 2 or LADA diabetes, and an eGFR of 90 or higher.
What is NaviDKD?
NaviDKD is a biomarker-based blood test which identifies the risk of kidney disease in people with diabetes.
How does it help clinicians and patients?
The results define a patient’s risk level for developing DKD and summarize personalized treatment opportunities. Using these insights, clinicians can make better informed decisions to preserve their patients' kidney health, avoid complications, and improve outcomes.
The Screening Process
-
![]()
1. Order
A healthcare professional places an order online, via email, or fax. Our team then contacts the patient to guide them through the entire process.
-
![]()
2. Ship
A NaviDKD lab kit is shipped directly to the patient’s home address. Clinics may also keep an inventory of test kits for patient distribution.
-
![]()
3. Test
The patient takes the kit to their lab for a fasting blood draw. The lab sends the completed kit back to Journey for analysis.
-
![]()
4. Results
The risk profile, outlined in a Compass Report™, are sent digitally to the patient and their healthcare professional to determine appropriate actions.
